USPSTF 2023: folic acid supplementation to prevent neural tube defects (reaffirmation)
A 2023 statement from the US Preventive Services Task Force (USPSTF) that reaffirms its advice that everyone planning a pregnancy, or who could become pregnant, should take a daily folic acid supplement containing 0.4 to 0.8 mg.
- Guideline
- In this atlas
Overview
Technical summary
USPSTF reaffirmation recommendation statement, JAMA 2023, volume 330, issue 5 (PubMed issue date 2023-08-01). The A recommendation and the task force wording of certainty are recorded as a claim on the folic acid page. The linked evidence report (PMID 37526714) is cited from the folic acid and neural tube defect pages. Whether a later edition exists was not checked. The guideline's source is the USPSTF final recommendation statement page, which gives the statement date that the recommendation decisions use; the JAMA statement stays cited in the claims.
About this guideline
- Issued by
- Edition
- USPSTF final recommendation statement, as shown on its page; also published as: Reaffirmation recommendation statement, JAMA 2023;330(5)
- Published
- 2023-08-01
- Status
- Not checked for a newer edition
- Scope
- Persons who are planning to or could become pregnant
Source
- Document
- Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication (USPSTF final recommendation statement page)
- Publisher
- U.S. Preventive Services Task Force
- Edition note
- Final recommendation statement page as fetched on 2026-10-14 (mx-uspstf-folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication.html). The date under the title is August 01, 2023.
Recommendations
Record details
- Record id
maternal:guideline-uspstf-2023-folic-acid- Content hash
102f831a09c08c8c8040dbd4af42371eee12511a9befe161717139fd14511f4c